Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect to chemotherapy treatment. It can cause symptoms that range from sensitivity to touch and numbness to neuropathic pain in ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

Multivariable analysis using the CART model was tuned using 10-fold cross-validation to identify baseline predictors for CIPN throughout chemotherapy. A receiver operating characteristic curve ...

In a recent study published in JAMA Internal Medicine, researchers examine the potential of neuromuscular training to prevent chemotherapy-induced peripheral neuropathy (CIPN). CIPN, a frequent ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapeutic agents that can potentially limit dosage during patient treatment and affects quality of life in ...

“Chemotherapy-induced peripheral neuropathy is a devastating consequence of cancer treatment regimens.” Despite the high prevalence and severity of CIPN, there is currently not an effective treatment ...

Gewandter et al, Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Chemotherapy-Induced Peripheral ...

a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), announced today that The ...

is developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) with potential portfolio expansion opportunities in other ...

COVINGTON, Ky., Nov. 14, 2024 /PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and ...